Edition:
India

Moleculin Biotech Inc (MBRX.OQ)

MBRX.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
25 Sep 2020
Change (% chg)

-- (--)
Prev Close
$0.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
337,149
52-wk High
$1.97
52-wk Low
$0.32

Select another date:

Thu, Jul 2 2020

BRIEF-Moleculin Provides Update On Annamycin Clinical Development

* MOLECULIN PROVIDES UPDATE ON ANNAMYCIN CLINICAL DEVELOPMENT

BRIEF-Moleculin Announces Preclinical Data Confirms Efficacy Of Annamycin In Lung Metastases

* MOLECULIN ANNOUNCES PRECLINICAL DATA CONFIRMS EFFICACY OF ANNAMYCIN IN LUNG METASTASES Source text for Eikon: Further company coverage:

BRIEF-Moleculin Announces Confirmatory In Vitro Analysis Of WP1122

* MOLECULIN ANNOUNCES CONFIRMATORY IN VITRO ANALYSIS OF WP1122

BRIEF-Moleculin Reports Submission To Expand Clinical Sites In European AML Trial

* MOLECULIN ANNOUNCES SUBMISSION TO EXPAND CLINICAL SITES IN EUROPEAN AML TRIAL

BRIEF-Moleculin Announces Common Stock Will Resume Trading On The Nasdaq On May 28

* MOLECULIN ANNOUNCES COMMON STOCK WILL RESUME TRADING ON THE NASDAQ ON MAY 28, 2020 Source text for Eikon: Further company coverage:

BRIEF-Moleculin Provides Update On Coronavirus Drug Development

* MOLECULIN BIOTECH - FDA HAS GRANTED CO'S REQUEST FOR A PRE-IND MEETING TO PROVIDE GUIDANCE REGARDING PLAN TO STUDY ITS DRUG CANDIDATE, WP1122

BRIEF-Nasdaq Halts Moleculin Biotech Inc

* NASDAQ - TRADING WILL REMAIN HALTED UNTIL MOLECULIN BIOTECH HAS SATISFIED REQUEST FOR ADDITIONAL INFORMATION Source text for Eikon: Further company coverage:

BRIEF-Moleculin Reports Nasdaq Trading Halt Pending Receipt Of Additional Info

* MOLECULIN ANNOUNCES NASDAQ TRADING HALT PENDING RECEIPT OF ADDITIONAL INFORMATION Source text for Eikon: Further company coverage:

BRIEF-Moleculin Provides Additional Comments Regarding Trading Halt

* MOLECULIN PROVIDES ADDITIONAL COMMENTS REGARDING TRADING HALT

BRIEF-Moleculin Announces Intention To Adjourn 2020 Annual Meeting Of Stockholders To June 15, 2020

* MOLECULIN ANNOUNCES INTENTION TO ADJOURN 2020 ANNUAL MEETING OF STOCKHOLDERS TO JUNE 15, 2020 Source text for Eikon: Further company coverage:

Select another date: